Program
Cetylpyridinium
Also written as “Cetylpyridinium chloride”, “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash” and “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”.
Its studies are mostly in Gingivitis · Dental Plaque · Pharyngitis · Diabetes Mellitus, Type 2 · Onychomycosis, led by 7 companies.
Drug pageCetylpyridinium: every studyMany companies study it; this page follows only the 15 they lead. All 27 studies, academic ones too, with its approvals and label.Who develops it
Each company that leads studies of it, as its sponsor page counts them.
| Company | Studies it leads | Furthest phase | First study | Next primary completion |
|---|---|---|---|---|
| Colgate Palmolive | 61 open or running | phase 4since Feb 6, 2015 | Jul 15, 2014 | Jan 2, 2028phase 4 · NCT07619729 |
| Procter and Gambleits history only | 20 open or running | phase 4since Sep 29, 2025 | Feb 28, 2012 | none ahead |
| Sanofiits history only | 20 open or running | phase 3since May 27, 2008 | May 27, 2008 | none ahead |
| Valenta Pharm JSCits history only | 22 open or running | phase 1since Feb 17, 2025 | Feb 17, 2025 | Dec 1, 2026phase 1 · NCT06859281 |
| Angelini Pharmaits history only | 10 open or running | phase 1since Apr 27, 2018 | Apr 27, 2018 | none ahead |
| NanoBioits history only | 10 open or running | phase 2since Mar 26, 2007 | Mar 26, 2007 | none ahead |
| Suzhou Neologics Bioscienceits history only | 11 open or running | phase 1since May 25, 2023 | May 25, 2023 | none ahead |
Also a collaborator on its studies: Cross Research.
How these companies relate is not in the registry. A license or acquisition is shown only with a dated source, such as a company release or filing.
History and studies of Colgate Palmolive only; the figures above count every company.
History and what’s ahead
From the studies’ own records, by the day each was first submitted. Purple marks an event: a company’s first study, a phase reached, a study stopped, a primary completion moved later (stops and moved dates are recorded from Sep 25, 2026). Dates ahead are the sponsors’ estimates.
- Jul 15, 2014First study: phase 3 study in Dental PlaqueFirst studyNCT02193165 · 120 enrolled · Puerto Rico
- Feb 6, 20152 phase 4 studies in Dental PlaqueNCT02366689, NCT02360995
- Jan 7, 2025Phase 3 study in GingivitisNCT06770114 · 80 enrolled · Italy
- Nov 24, 2025Phase 3 study in GingivitisNCT07263698 · 80 enrolled · Italy
- May 26, 2026Phase 4 study in Diabetes Mellitus, Type 2NCT07619729 · 10,000 planned · United States
Ahead
- Jan 2, 2028Primary completion: phase 4 study in Diabetes Mellitus, Type 2NCT07619729
TargetBeta
Not stated by its company or a source we have read. Most early programs say nothing of it.
Studies
All 6 Colgate Palmolive leads, newest first. Each opens its study page.
| Study | Phase | Status | Primary completion | Size |
|---|---|---|---|---|
| NCT07619729Diabetes Mellitus, Type 2 · United States | 4 | By invitation | Jan 2, 2028 | 10,000 |
| NCT07263698Gingivitis · Italy | 3 | Completed | Feb 27, 2026 | 80 |
| NCT06770114Gingivitis · Italy | 3 | Completed | May 9, 2022 | 80 |
| NCT02366689Dental Plaque · United States | 4 | Completed | Dec 2014 | 179 |
| NCT02360995Dental Plaque · United States | 4 | Completed | Aug 2014 | 129 |
| NCT02193165Dental Plaque · Puerto Rico | 3 | Completed | Aug 2014 | 120 |
How it is read
Names in the registry
- “Cetylpyridinium chloride”, 2 entries
- “Cetylpyridinium Chloride (CPC) and Zinc Lactate Mouthwash”, 1 entry
- “cetylpyridinium chloride (CPC), zinc lactate and sodium fluoride Mouthwash”, 1 entry
- “Cetylpyridinium Chloride, Zinc Lactate and Hyaluronic Acid Mouthwash”, 1 entry
- “Cetylpyridinium Chloride (CPC)”, 1 entry
Conditions, from the studies’ own filings
- Gingivitis, 4 studies
- Dental Plaque, 3 studies
- Pharyngitis, 2 studies
- Diabetes Mellitus, Type 2, 1 study
- Onychomycosis, 1 study
First seen by our ledger Nov 13, 2026.
What this can’t show
- Only studies on ClinicalTrials.gov. Studies only in China’s, Europe’s or other registries are missing here.
- Deals, prices and results are not in the registry. A licence or acquisition shows only with a dated source.
- Primary completion dates are the sponsors’ estimates and often move.
- A study counts here when it names this program among the drugs it tests; one that writes it only beside a placebo may be missed.